• InnoSer Announces Joint Initiative with Hasselt University/BIOMED to Support Preclinical Multiple Sclerosis Research

    Wednesday October 16th 2024

  • SwiftPharma and AntoXa to present plant-made anti-ricin antibody technology to NATO expert panel

    Thursday August 15th 2024

  • Rejuvenate Biomed and SAS tap AI to develop disease-agnostic drug repurposing discovery tools

    Thursday August 1st 2024

  • Biotech company SwiftPharma receives capital injection to achieve ambitious growth

    Thursday June 27th 2024

  • SwiftPharma to Join Groundbreaking €41 Million PharmECO Project.

    Wednesday June 26th 2024

  • New software from UHasselt and ZEISS shows in sharp detail how biomolecules move in cells.

    Monday June 17th 2024

  • Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indications

    Friday May 31st 2024

  • BIO INX and Readily3D Announce Collaboration to Advance Volumetric Bioprinting with Cutting-edge Gel-MA Based Ink

    Wednesday May 22nd 2024

  • Your news here?

  • Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.

    Friday May 17th 2024

  • Labconsort and NEKTARI join forces for a more sustainable and social industry

    Saturday April 20th 2024

  • BioLizard and AbnomX announce partnership

    Tuesday April 2nd 2024


Strategic Partners